Top

Cancer Cell International

Published in:

Open Access 01-12-2021 | Tamoxifen | Correction

Correction to: Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p

Authors: Jianhui Liu, Shaoliang Zhu, Wei Tang, Qinghua Huang, Yan Mei, Huawei Yang

Published in: Cancer Cell International | Issue 1/2021

Excerpt

Following the publication of the original article [1], we were notified of an error in Fig. 4. …

Liu J, Zhu S, Tang W, Huang Q, Mei Y, Yang H. Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p. Cancer Cell Int. 2021;21:55. https://doi.org/10.1186/s12935-020-01659-0.CrossRefPubMedPubMedCentral

Title: Correction to: Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p
Authors: Jianhui Liu
Shaoliang Zhu
Wei Tang
Qinghua Huang
Yan Mei
Huawei Yang
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Tamoxifen
Published in: Cancer Cell International / Issue 1/2021
Electronic ISSN: 1475-2867
DOI: https://doi.org/10.1186/s12935-021-01944-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Downregulation of tumor‐derived exosomal miR-34c induces cancer‐associated fibroblast activation to promote cholangiocarcinoma progress

FOXH1 promotes lung cancer progression by activating the Wnt/β-catenin signaling pathway

Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer

Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer

LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC

Combating drug resistance in acute myeloid leukaemia by drug rotations: the effects of quizartinib and pexidartinib

Keynote webinar | Spotlight on antibody–drug conjugates in cancer